Molecular Imaging of Coronary Plaques

Size: px
Start display at page:

Download "Molecular Imaging of Coronary Plaques"

Transcription

1 Molecular Imaging of Coronary Plaques Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute CSMC Professor of Medicine David Geffen School of Medicine at UCLA Zahi A. Fayad, PhD, FAHA, FACC Professor of Radiology Rdil and Medicine Mdii (Cardiology) Director, Translational and Molecular Imaging Institute Mount Sinai School of Medicine, New York, NY 1

2 David Newby, MD Mark kdweck, MD University of Edinburgh Understanding CAD is Changing Fibroatheroma: Stable Plaque Narula & Willerson, JACC (ed) TCFA with Cap Rupture Narula & Virmani,

3 Anatomical to Molecular Imaging Tissue level Anatomical level Cellular and molecular Level Imaging Probes Sensitivity PET MRI CT Radioactive Small Molecules Paramagnetic Superparamagnetic Radiodense Payload required 3

4 Imaging Probes Sensitivity PET MRI CT Radioactive Small Molecules Paramagnetic Superparamagnetic Radiodense Payload required Orders of Magnitude in Drug (Contrast Agent) Dosing: Exploiting the Exploratory IND (eind) Mechanism Modality CT Typical Intravenous Human Dose (g) 75 cc of 930 mm solution = 56 g MRI 15 cc of 500 mm solution = 7g Regular Strength Tylenol = 600 mg Optical (NIR) 5 cc of a 1 mm solution = 5 mg FDA definition of micro-dosing = 100 µg SPECT 20 mci (10,000 Ci/mmol) = 2 µg eind PET 20 mci (10,000 Ci/mmol) = 2 µg Eligible 4

5 FDG Uptake in Carotid Artery Disease FDG-PET CTa Fused 10 FDG accumulation Rate/sec 5 P<0.01 SymptomsNo symptomatic asymptomatic symptoms Weissberg P et al., Circulation 2004 Simvastatin Attenuates Plaque Inflammation Tahara et al JACC

6 Tawakol et al JACC 2006 Measuring atherosclerosis FDG PET/CT Identifies cells with increased metabolic activity Measures plaque glycolysis (inflammation) Usedto assess changes inplaque inflammation Statins, anti inflammatory drugs, TZDs Predictor of future risk of atherothrombosis 18F FDG PET/CT imaging 5 PET/C CT CT 1 Rudd et al. Circulation. 2002;105; ; 2 Rudd et al. J Am Coll Cardiol. 2010;55: ; 3 Tahara et al. J Am Coll Cardiol. 2006;48: ; 4 Lee et al. J Nucl Med. 2008;49: ; 5 Fayad et al. The Lancet 2011;378:

7 FDG Visualization of Inflamed Coronary Plaque FDG Visualization of Inflamed Coronary Plaque 7

8 27 PCI patients studied with FDG PET/CT 1-6 days p PDI: 20 STEMI; 7 stable CAD Increased uptake in: 12/20 STEMI; 1/7 Stable Cheng, et al JNM in press 2012 Figure 3 FDG Uptake at Stent Site in Acute STEMI CORONAL AXIAL SAGITTAL LAD STEMI RCA STEMI LCX STEMI Cheng, et al JNM in press

9 Absence of FDG Uptake at Stent Site in Stable CAD CORONAL AXIAL RCA stent for stable CAD SAGITTAL LAD stent for stable CAD Cheng, et al JNM in press 2012 Sinusas lecture: ASNC

10 Direct Imaging of Myocardial Ischemia (FDG) He et al, Narula, Jain. Circulation Fluoro-Deoxy Glucose The ring of fire Aortic Ring Inflammation Dweck et al. Circulation 2012;125:in press 10

11 Sodium 18 Fluoride Aortic Stenosis Dweck et al. Circulation 2012;125: Fluoro-Deoxy Glucose The ring of fire Dweck et al. Circulation 2012;125:

12 Calcification more important than Inflammation Dweck et al. Circulation 2012;125:76-86 Dweck et al JACC

13 F-18 NaF Uptake in Coronary Plaque Dweck M Newby D ACC year FRS for Controls and Patients with CAC who did and did not have 18F-NaF uptake Dweck et al JACC

14 Tc-99m Annexin V: Probe for Vulnerable Plaque TNF or Fas Ligand Annexin V Detection of the apoptotic cell binding followed by 2D-crystallization TNFR or death domains mediated signaling scramblase translocase CD ? floppase activation of the executioner of apoptosis Courtesy Chris Reutlingsperger, Maastricht University ANT L Annexin-V Imaging For Apoptosis A Old TIA B Recent TIA Transverse Coronal C D Keitselaar, Hofstra, Narula; NEJM 2004 Annexin IHC in Endarterectomy 14

15 RGD tracer uptake is increased in atherosclerotic plaque Oil Red O 18 F RGD uptake αvβ3 Autoflour Tamarappoo, et al 2010 Direct Imaging of Myocardial Ischemia (FDG) He et al, Narula, Jain. Circulation

16 Molecular Imaging to Detect Vulnerable Plaque Clinial Applications Emerging in 2020 Langer et al. JACC 2008; 52:1-12. Molecular Imaging Across CAD Spectrum Conventional Imaging Coronary Calcium/ Plaque Stenosis/ Perfusion Function Geometry Coronary Atherosclerosis Myocardial Ischemia/ Infarction Heart Failure Molecular Imaging Disease Activity Plaque Vulnerability Remodeling Guiding Specific therapy 16

17 17

SPECT CT Current Status and Future Direction Nuclear Cardiology

SPECT CT Current Status and Future Direction Nuclear Cardiology SPECT CT Current Status and Future Direction Nuclear Cardiology BIR London 25 th February 2013 Nik Sabharwal Consultant Cardiologist Oxford Heart Centre nikant.sabharwal@ouh.nhs.uk No conflict of interest

More information

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute Professor of Medicine and Imaging Cedars-Sinai

More information

Η Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ

Η Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ Η Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ huma human n Setting diagnosis of the early stages of chronic diseases (i.e cancer, neuropsychiatric, cardiovascular disorders), in

More information

Multimodality Cardiac Imaging: Its Use in the Era of Value-based Reimbursement

Multimodality Cardiac Imaging: Its Use in the Era of Value-based Reimbursement Multimodality Cardiac Imaging: Its Use in the Era of Value-based Reimbursement Daniel S., MD Director, Cardiac Imaging Cedars-Sinai Heart Institute Professor of Medicine UCLA School of Medicine ACC DC

More information

The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the

The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the limbs and major organs. A range of important pathologies

More information

Diagnostic and Prognostic Value of Coronary Ca Score

Diagnostic and Prognostic Value of Coronary Ca Score Diagnostic and Prognostic Value of Coronary Ca Score Dr. Ghormallah Alzahrani Cardiac imaging division, Adult Cardiology department Prince Sultan Cardiac Center ( PSCC) Madina, June 2 Coronary Calcium

More information

Assessment Of Myocardial Viability

Assessment Of Myocardial Viability Assessment Of Myocardial Viability James K. Min, MD FACC President, Society of Cardiovascular Computed Tomography Associate Professor of Medicine, UCLA School of Medicine Associate Professor of Medicine

More information

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Prof. Juhani Knuuti, MD, FESC Turku, Finland Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial

More information

Cardiovascular Imaging

Cardiovascular Imaging Cardiovascular Imaging Cardiovascular Imaging Cardio and Vascular Imaging Vascularization / Angiogenesis Cardiovascular Imaging metabolic imaging of the heart myocardial perfusion imaging Cardiac CT Vascularization

More information

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens Overview: 1 Definition-Pathology 2 3 Diagnostic Strategies Invasive Non Invasive Prognostic Value of Detection 4 Treatment

More information

Calcium scoring Clinical and prognostic value

Calcium scoring Clinical and prognostic value Calcium scoring Clinical and prognostic value Matthijs Oudkerk Professor and Chair of Radiology University Medical Center Groningen, University of Groningen Groningen, The Netherlands Sofia 2011 13 May

More information

FFR-CT Not Ready for Primetime

FFR-CT Not Ready for Primetime FFR-CT Not Ready for Primetime Leslee J. Shaw, PhD, MASNC, FACC, FAHA, FSCCT R. Bruce Logue Professor of Medicine Co-Director, Emory Clinical CV Research Institute Emory University School of Medicine Atlanta,

More information

CT or PET/CT for coronary artery disease

CT or PET/CT for coronary artery disease CT or PET/CT for coronary artery disease Rotterdam 2012 Juhani Knuuti, MD, PhD, FESC Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi Turku PET Centre University of Turku Åbo Akademi

More information

Rational use of imaging for viability evaluation

Rational use of imaging for viability evaluation EUROECHO and other imaging modalities 2011 Rational use of imaging for viability evaluation Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology, CHU Liège, Belgium

More information

The Role of Nuclear Imaging in Heart Failure

The Role of Nuclear Imaging in Heart Failure The Role of Nuclear Imaging in Heart Failure Mouaz H. Al-Mallah, MD MSc FESC Associate Professor of Medicine Consultant Cardiologist and Division Head, Cardiac Imaging King Abdulaziz Cardiac Centre, National

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Comparative Advantages of PET Over SPECT: Is PET Really Better? Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute Professor of Medicine University of Missouri-Kansas

More information

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis Update in Nuclear Imaging of Amyloidosis and Sarcoidosis Balaji Tamarappoo MD, PhD, Cedars-Sinai Heart Institute and Biomedical Imaging Research Institute Cedars-Sinai Medical Center Los Angeles, CA, USA.

More information

State-of-the-Art SPECT/CT: Cardiac Imaging

State-of-the-Art SPECT/CT: Cardiac Imaging State-of-the-Art SPECT/CT: Cardiac Imaging Ernest V Garcia*, PhD Endowed Professor in Cardiac Imaging Director, Nuclear Cardiology R&D Laboratory Disclosure: Dr. Garcia receives royalties from the sale

More information

FRIDAY, JANUARY 18, :00 The Nuclear Cardiology Consultation: Pearls and Impact on Outcomes Daniel S. Berman, MD

FRIDAY, JANUARY 18, :00 The Nuclear Cardiology Consultation: Pearls and Impact on Outcomes Daniel S. Berman, MD FRIDAY, JANUARY 18, 2019 7:15 AM Registration, Breakfast & Exhibits 7:45 Course Overview and Objectives Daniel S. Berman, MD SESSION 1: ADVANCES IN SPECT and PET 8:00 The Nuclear Cardiology Consultation:

More information

CASE from South Korea

CASE from South Korea CASE from South Korea Bon-Kwon Koo, MD, PhD, Seoul, Korea Outpatient clinic of a non-interventional cardiologist F/56 Chief complaint: Angina with recent aggravation, CCS II~III Brief history: # Stroke

More information

Imaging of Coronary Atherosclerosis. Dr Marc Dweck BHFSenior Lecturer Edinburgh Heart Centre& University of Edinburgh

Imaging of Coronary Atherosclerosis. Dr Marc Dweck BHFSenior Lecturer Edinburgh Heart Centre& University of Edinburgh Imaging of Coronary Atherosclerosis Dr Marc Dweck BHFSenior Lecturer Edinburgh Heart Centre& University of Edinburgh Echo CT Angiography& Plaque MRI - Assess Anginal Symptoms SPECT PERFUSION - Risk Stratification

More information

Myocardial Perfusion: Positron Emission Tomography

Myocardial Perfusion: Positron Emission Tomography Myocardial Perfusion: Positron Emission Tomography TH. Schindler, MD University Hospitals of Geneva, Cardiovascular Center, Geneva, Switzerland ESC 2010 Stockholm Personal Disclosure Research Grant support

More information

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool Vulnerable Plaque features on coronary CT Jin Ho Choi, MD, PhD Department of Internal Medicine, Emergency Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea IPS /

More information

Current and Future Imaging Trends in Risk Stratification for CAD

Current and Future Imaging Trends in Risk Stratification for CAD Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction

More information

Imaging Atheroma The quest for the Vulnerable Plaque

Imaging Atheroma The quest for the Vulnerable Plaque Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing

More information

PET: quantification of perfusion and beyond

PET: quantification of perfusion and beyond PET: quantification of perfusion and beyond Juhani Knuuti Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi 27.8.2012 1 Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial

More information

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Alexandre C Ferreira, MD Clinical Chief of Cardiology Jackson Health System Director, Interventional Cardiology Training

More information

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical Center, Torrance, CA

More information

Advances in Cardiovascular Molecular Imaging: Hybrid SPECT/CT, PET/CT, and PET/MRI

Advances in Cardiovascular Molecular Imaging: Hybrid SPECT/CT, PET/CT, and PET/MRI Advances in Cardiovascular Molecular Imaging: Hybrid SPECT/CT, PET/CT, and PET/MRI Albert J. Sinusas, MD Professor of Medicine & Radiology Director, Advanced Cardiovascular Imaging Director, Yale Translational

More information

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas Emerging role of PET in nuclear cardiology Dr. Erick Alexánderson Rosas PET principles e + e - 180 PET/CT Cyclotron Unit UNAM Cyclotron Radiopharmacy PET Camera CT PET PET CT Perfusion Anatomic evaluation

More information

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical

More information

Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN

Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN VUMC PET/CT conference 2009 82 Rb Cardiac Perfusion PET 82 Rb is

More information

Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE.

Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE. Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE. Nuclear Cardiology I - A remaining need of a functional information on myocardial perfusion II - The future: - combining

More information

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology Assessment of Myocardial Viability Jamshid Maddahi, M.D., FACC, FASNC Professor Molecular and Medical Pharmacology (Nuclear Medicine) and Medicine (Cardiology) David Geffen School of Medicine at UCLA Director,

More information

Testing the Asymptomatic CAD Patient: When and Why?

Testing the Asymptomatic CAD Patient: When and Why? Testing the Asymptomatic CAD Patient: When and Why? Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute Professor of Medicine University of Missouri-Kansas

More information

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF) Evaluation of Myocardial Viability: What Have We Learned from STICH? Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute CSMC 2013 Professor of Medicine David Geffen School of Medicine

More information

Noninvasive Coronary Imaging: Plaque Imaging by MDCT

Noninvasive Coronary Imaging: Plaque Imaging by MDCT Coronary Physiology & Imaging Summit 2007 Noninvasive Coronary Imaging: Plaque Imaging by MDCT Byoung Wook Choi Department of Radiology Yonsei University, Seoul, Korea Stary, H. C. et al. Circulation

More information

Cardiac PET. John Buscombe

Cardiac PET. John Buscombe Cardiac PET John Buscombe Why PET? Improved resolution-not really required in cardiology Improved sensitivity this may be important-financially as reduced acquisition time Improved attenuation correction-good

More information

Perspectives and Opportunities for Nanomedicine in the Management of Atherosclerosis

Perspectives and Opportunities for Nanomedicine in the Management of Atherosclerosis Perspectives and Opportunities for Nanomedicine in the Management of Atherosclerosis Zahi A. Fayad, PhD, FAHA, FACC Professor of Radiology and Medicine (Cardiology) Director, Translational and Molecular

More information

Potential recommendations for CT coronary angiography in athletes

Potential recommendations for CT coronary angiography in athletes Potential recommendations for CT coronary angiography in athletes B.K. Velthuis Dept. of Radiology UMC Utrecht, the Netherlands EuroPRevent 15 April 2011 Declaration of interest Philips Medical Systems

More information

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries

More information

Hybrid Imaging Improving Nuclear Cardiology Practice

Hybrid Imaging Improving Nuclear Cardiology Practice Lippincott Williams & Wilkins, - Nuclear Medicine teaching File, 2009 Hybrid Imaging Improving Nuclear Cardiology Practice João V. Vitola, MD, PhD Cardiologist and Nuclear Medicine Physician Quanta Diagnostico

More information

Disclosures CORONARY CALCIUM SCORING REVISITED. Learning Objectives. Scoring Methods. Consultant for M2S, Inc. Coronary Calcium Scoring: Software

Disclosures CORONARY CALCIUM SCORING REVISITED. Learning Objectives. Scoring Methods. Consultant for M2S, Inc. Coronary Calcium Scoring: Software CORONARY CALCIUM SCORING REVISITED Disclosures Consultant for M2S, Inc. Julianna M. Czum, MD Director, Division of Cardiothoracic Imaging Department of Radiology Dartmouth Hitchcock Medical Center Assistant

More information

Maria Angela S. Cruz-Anacleto, MD

Maria Angela S. Cruz-Anacleto, MD Maria Angela S. Cruz-Anacleto, MD 57/Female Menopausal Non-HTN, non-dm Hypothyroid (s/p RAI 1997) Levothyroxine 100 ug OD 5 Months PTA Chest discomfort Stress Echocardiography 5 Months PTA Chest discomfort

More information

Pearls & Pitfalls in nuclear cardiology

Pearls & Pitfalls in nuclear cardiology Pearls & Pitfalls in nuclear cardiology Maythinee Chantadisai, MD., NM physician Division of Nuclear Medicine, Department of radiology, KCMH Principle of myocardial perfusion imaging (MPI) Radiotracer

More information

Diabetes and Occult Coronary Artery Disease

Diabetes and Occult Coronary Artery Disease Diabetes and Occult Coronary Artery Disease Mun K. Hong, MD, FACC, FSCAI Director, Cardiac Catheterization Laboratory & Interventional Cardiology St. Luke s-roosevelt Hospital Center New York, New York

More information

Pathology of Coronary Artery Disease

Pathology of Coronary Artery Disease Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology

More information

Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: State-of-the-Art Updates and 101 Evidence-Based Case Reviews

Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: State-of-the-Art Updates and 101 Evidence-Based Case Reviews AGENDA Wednesday, May 9 4:00 p.m. 6:00 p.m. Registration Thursday, May 10 7:00 a.m. Registration and Continental Breakfast 7:45 a.m. Course Overview and Objectives Session #1: Advances in SPECT and PET

More information

Is computed tomography angiography really useful in. of coronary artery disease?

Is computed tomography angiography really useful in. of coronary artery disease? Is computed tomography angiography really useful in screening patients with high risk of coronary artery disease? Myeong-Ki Hong, M.D. Ph D Professor of Medicine Division of Cardiology, Severance Cardiovascular

More information

F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques

F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques Review Article Nuclear Medicine http://dx.doi.org/10.3348/kjr.2015.16.6.1257 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2015;16(6):1257-1261 F-18 Fluoride Positron Emission Tomography-Computed Tomography

More information

Multi-Modality Imaging of Atherosclerosis in HIV Ahmed Tawakol, MD

Multi-Modality Imaging of Atherosclerosis in HIV Ahmed Tawakol, MD Multi-Modality Imaging of Atherosclerosis in HIV Ahmed Tawakol, MD Director, Integrative Bio-Imaging Trials Program Co-Director Cardiac MR PET CT Program Massachusetts General Hospital Harvard Medical

More information

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users February 1 5, 2011 University of Santo Tomas Hospital Angelo King A-V Auditorium Manila,

More information

Recent Advances in Nuclear Cardiology, Cardiac CT, and Cardiac MRI: Applications for CAD in the Era of Value-based Imaging

Recent Advances in Nuclear Cardiology, Cardiac CT, and Cardiac MRI: Applications for CAD in the Era of Value-based Imaging Recent Advances in Nuclear Cardiology, Cardiac CT, and Cardiac MRI: Applications for CAD in the Era of Value-based Imaging Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute Professor

More information

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Cottrell Memorial Lecture Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Stephen Nicholls MBBS PhD @SAHMRI_Heart Disclosures Research support: AstraZeneca,

More information

MD F A F C A C MAS A N S C

MD F A F C A C MAS A N S C Myocardial Perfusion Imaging and Coronary Calcium Scoring: Complimentary or Competitive David Wolinsky MD FACC MASNC Section Head Nuclear Cardiology, Cleveland Clinic Florida Immediate Past President,

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study James K. Min 1 ; Jonathon Leipsic 2 ; Michael J. Pencina 3 ; Daniel S. Berman 1 ; Bon-Kwon

More information

THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift

THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift Angioplasty Summit TCT ASIA Seoul, Korea, april 23rd, 2008 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands

More information

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy?

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy? Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy? John McB. Hodgson, M.D., FSCAI Chairman, Department of Cardiology Geisinger Health System Wilkes Barre,, Pa Disclosure Information

More information

Machine learning improves image analysis prognosis and diagnosis in cardiac imaging

Machine learning improves image analysis prognosis and diagnosis in cardiac imaging Machine learning improves image analysis prognosis and diagnosis in cardiac imaging Some software described in this presentation is owned by Cedars-Sinai Medical Center, which receives or may receive royalties

More information

Willem J.M. Mulder, Ph.D. Assistant Professor of Radiology Assistant Professor of Gene and Cell Medicine Director Nanomedicine Laboratory

Willem J.M. Mulder, Ph.D. Assistant Professor of Radiology Assistant Professor of Gene and Cell Medicine Director Nanomedicine Laboratory Willem J.M. Mulder, Ph.D. Assistant Professor of Radiology Assistant Professor of Gene and Cell Medicine Director Nanomedicine Laboratory Noordwijkerhout, The Netherlands 17-18 March 2011 Nanometer (10-9

More information

Positron emission tomography and molecular imaging

Positron emission tomography and molecular imaging Positron emission tomography and molecular imaging EHH, May, 2010 Juhani Knuuti Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi PET Imaging in Medicine MRI CT MRI PET US SPET MEG

More information

Atypical pain and normal exercise test

Atypical pain and normal exercise test Atypical pain and normal exercise test F. Mut, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history 67-year old male with several coronary risk factors. Atypical

More information

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet? Evolving Role of Coronary CTA in Primary Cardiovascular Disease Prevention: Are We There Yet? Ron Blankstein, M.D., F.A.C.C. Co-Director, Cardiovascular Imaging Training Program Associate Physician, Preventive

More information

Coronary Artery Thermography

Coronary Artery Thermography Coronary Artery Thermography The 10th Anniversary, Interventional Vascular Therapeutics Angioplasty Summit 2005 TCT Asia Pacific Christodoulos Stefanadis Professor of Cardiology Athens Medical School In

More information

New Challenges in Nuclear Cardiology Practice

New Challenges in Nuclear Cardiology Practice New Challenges in Nuclear Cardiology Practice Brian G. Abbott, MD, FACC, FASNC, FAHA President, ASNC 2016 Associate Professor of Medicine Warren Alpert Medical School of Brown University Director, Cardiovascular

More information

An Epidemic of Heart Disease The Silent Killer. Professor Mike Kirby FRCP University of Hertfordshire Institute of Diabetes for Older People

An Epidemic of Heart Disease The Silent Killer. Professor Mike Kirby FRCP University of Hertfordshire Institute of Diabetes for Older People An Epidemic of Heart Disease The Silent Killer Professor Mike Kirby FRCP University of Hertfordshire Institute of Diabetes for Older People Initial clinical presentation of CAD Angina MI Atypical CP Death

More information

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute Which Test When? Avoid the Stress of Stress Testing Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute Outline Understand the importance of coronary artery disease assessment Understand the basics

More information

MEDICAL UNIVERSITY of SOUTH CAROLINA

MEDICAL UNIVERSITY of SOUTH CAROLINA U. Joseph Schoepf, MD Prof. (h.c.), FAHA, FSCBT-MR, FNASCI, FSCCT Professor of Radiology, Medicine, and Pediatrics Director, Division of Cardiovascular Imaging MEDICAL UNIVERSITY of SOUTH CAROLINA Disclosures

More information

Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation.

Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation. Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation. Ces fonds proviennent essentiellement d industriels travaillant dans les domaines de l imagerie

More information

Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017

Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017 Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017 F Prati San Giovanni H. and CLI Foundation, Rome Euro Image Research Che cosa preoccupa il cardiologo

More information

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus OPTICAL COHERENCE TOMOGRAPHY (OCT) IVUS and OCT IVUS OCT

More information

Cardiac CT and MR Techniques to Identify the Vulnerable Patient. Are we out of the Gate yet?

Cardiac CT and MR Techniques to Identify the Vulnerable Patient. Are we out of the Gate yet? Cardiac CT and MR Techniques to Identify the Vulnerable Patient Are we out of the Gate yet? Paolo Raggi, MD Emory University, Atlanta, GA Naghavi, M. et al. Circulation 2003;108:1664-1672 1 Serologic Markers

More information

Disclosure Information

Disclosure Information Coronary CTA Pearls and Pitfalls Ricardo C. Cury, MD, FSCCT, FAHA, FACC Chairman of Radiology Radiology Associates of South Florida Director of Cardiac Imaging Miami Cardiac and Vascular Institute Past-President

More information

Risk Stratification for CAD for the Primary Care Provider

Risk Stratification for CAD for the Primary Care Provider Risk Stratification for CAD for the Primary Care Provider Shimoli Shah MD Assistant Professor of Medicine Directory, Ambulatory Cardiology Clinic Knight Cardiovascular Institute Oregon Health & Sciences

More information

Welcome! To submit questions during the presentation: or Text:

Welcome! To submit questions during the presentation:   or Text: Welcome! To participate in the interactive Q & A please do the following: 1. Download the Socrative Student App 2. Enter Teacher s Room Code: ZD0F3X5Q 3. Select Quiz: Intermountain Cardiac Stress Testing

More information

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010 ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010 CORONARY ARTERY DISEASE AND NUCLEAR IMAGING: AN UPDATE PERFUSION SCINTIGRAPHY IN HIGH-RISK ASYMPTOMATIC PATIENTS Pasquale Perrone Filardi Federico

More information

Benefit of Performing PCI Based on FFR

Benefit of Performing PCI Based on FFR Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided

More information

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images) Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images) Victor Cheng, M.D. Director, Cardiovascular CT Oklahoma Heart Institute 1 Disclosures Tornadoes scare me 2 Treating CAD Fixing

More information

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Quanta Diagnostico Nuclear Curitiba, Brazil Clinical history Male 63 y.o.,

More information

Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute

Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute Coronary Artery Calcium Vimal Ramjee, MD FACC The Chattanooga Heart Institute Disclosures I have no conflicts of interest to disclose. Objectives Recognize the utility of coronary artery calcium scoring

More information

FESC, FACC, MAHA, MSCAI, MEAPSI, ESH

FESC, FACC, MAHA, MSCAI, MEAPSI, ESH «Απεικόνιση και φυσιολογία στο αιμοδυναμικό εργαστήριο». Eυάλωτη αθηρωματική πλάκα. Πού βρισκόμαστε? Ηλίας Α. Σανίδας MD, PhD, FESC, FACC, MAHA, MSCAI, MEAPSI, ESH Specialist Επεμβατικός Kαρδιολόγος Επιμελητής,

More information

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING MEDICAL POLICY PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.

More information

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA CT Imaging of Atherosclerotic Plaque William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA PREVALENCE OF CARDIOVASCULAR DISEASE In 2006 there were 80 million

More information

Debate Should we use FFR? I will say NO.

Debate Should we use FFR? I will say NO. Debate Should we use FFR? I will say NO. Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol Gwon Research fund from Abbott Korea

More information

Advanced Imaging MRI and CTA

Advanced Imaging MRI and CTA Advanced Imaging MRI and CTA Who and why may benefit. Matthew W. Martinez, M.D. FACC Lehigh Valley Health Network Director, Cardiovascular Imaging Learning Objectives Review basics of CMR and CTA Review

More information

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly

More information

Integrated PET/CT systems State of the art and Clinical Applications

Integrated PET/CT systems State of the art and Clinical Applications Integrated PET/CT systems State of the art and Clinical Applications V. Bettinardi Nuclear Medicine Dep. Scientific Institute San Raffaele Hospital Milan Italy The announcement of a new Diagnostic Imaging

More information

PET myocard perfusion & viability Riemer Slart

PET myocard perfusion & viability Riemer Slart PET myocard perfusion & viability Riemer Slart Nuclear Medicine Physician Dept. of Nuclear Medicine and Molecular Imaging University Medical Center Groningen, the Netherlands Professor in Molecular Imaging,

More information

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging Imaging the Vulnerable Plaque David A. Dowe, MD Atlantic Medical Imaging Why is this so important? The Acute Situation Coronary disease-important Diagnosis of cardiovascular disease cost $148 billion in

More information

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος Δρ Αναστασία Κίτσιου Διευθύντρια, Καρδιολογική Κλινική, Σισμανόγλειο ΓΝΑ Chair, Education Committee, Section on Nuclear Cardiology & Cardiac CT, EACVI, ESC

More information

Advantages of PET Myocardial Imaging

Advantages of PET Myocardial Imaging Advantages of PET Myocardial Imaging Legal Disclaimers These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.

More information

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem

More information

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI Cardiac Imaging Kimberly Delcour, DO, FACC Director, Cardiac CT Mahi Ashwath, MD, FACC, FASE Director, Cardiac MRI Cardiac Imaging Discuss the clinical applications of and indications for: Cardiac CT Nuclear

More information

OCT Findings: Lesson from Stable vs Unstable Plaques

OCT Findings: Lesson from Stable vs Unstable Plaques ANGIOPLASTY SUMMIT TCTAP 2010 Imaging Workshop OCT Findings: Lesson from Stable vs Unstable Plaques Giulio Guagliumi MD Ospedali Riuniti di Bergamo, Italy DISCLOSURE OF FINANCIAL INTERESTS Consultant Boston

More information

Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm

Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm Mark J. Sands, MD Vice Chairman, Imaging Institute Clinical Operations and Quality Objectives Review of available radiologic

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Can IVUS Define Plaque Features that Impact Patient Care?

Can IVUS Define Plaque Features that Impact Patient Care? Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center

More information

Title. CitationJournal of Nuclear Cardiology, 23(3): Issue Date Doc URL. Rights. Type. File Information

Title. CitationJournal of Nuclear Cardiology, 23(3): Issue Date Doc URL. Rights. Type. File Information Title Incidental focal myocardial 18F-FDG uptake indicatin Aikawa, Tadao; Naya, Masanao; Manabe, Osamu; Obara, Author(s) Hiroyuki CitationJournal of Nuclear Cardiology, 23(3): 596-598 Issue Date 2016-06

More information

New Paradigms in Predicting CVD Risk

New Paradigms in Predicting CVD Risk New Paradigms in Predicting CVD Risk Imaging as an Integrator of Lifetime Risk Exposure Michael J. Blaha MD MPH Presented by: Michael J. Blaha September 24, 2014 1 Talk Outline Risk factors vs. Disease

More information